The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.

Login to TechFinder » 

Search Type:  Keyword(s)
Searched On:tumor targeting

Page 1 of 1 (7 results)
1 All

Docket NumberTitleKeywordsPublic Release Date
1S11-151PRKCi, atypical protein kinase C, inhibitors for hedgehog dependent cancersKeywords5/30/2017
2S16-086Synthesis of uniformly-sized, water-soluble gold nanoparticlesKeywords7/25/2016
3S10-393Cancer vaccine with EGFRvIII-derived peptideKeywords9/24/2014
4S14-171A method for tracking moving sources with PETKeywords8/13/2014
5S10-397Scaffold-kinase interaction blockade for treatment of RAS/MAPK-Pathway driven cancersKeywords6/27/2014
6S11-366Mesenchymal stem cells as targeted-delivery vehicles for image-guided cancer treatmentKeywords5/22/2014
7S10-275αVβ6 integrin binding peptides for cancer therapy and imagingKeywords6/18/2013


Show Interactive Map and Timeline
Show a compact interactive summary of the docket shown visually. Navigate to additional information and related projects for broader context.